Upfront. As a one-time, non-refundable consideration of the rights and licence granted by Ascendis to Licensee under this Agreement, Licensee shall issue and transfer to Ascendis [***] Series A-1 Preferred Shares in XXXXX Pharmaceuticals, corresponding to a total value of US[***] at the Effective Date.
Appears in 4 contracts
Samples: Exclusive Licence Agreement, Exclusive Licence Agreement (Ascendis Pharma a/S), Exclusive Licence Agreement (Ascendis Pharma a/S)